title: The FDA Revises Restrictions on Metformin Use in Kidney Impairment.
authors.affiliation: Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.
authors.forename: Diane S
authors.initials: DS
authors.lastname: Aschenbrenner
mesh_terms: D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005919:Glomerular Filtration Rate; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008687:Metformin / Q000097:blood / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin